lobbying_activities: 2817034

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2817034	2f8c9ff2-aefa-4c84-b800-be44c91e1aaa	Q2	SQUIRE PATTON BOGGS	30906	ASTRAZENECA UK LTD.	2022	second_quarter	ENV	Seeking consideration of AstraZeneca's intention to substitute zero Global Warming Potential (GWP) gases for current propellants in its metered dose inhalers.	Environmental Protection Agency (EPA),Health & Human Services, Dept of (HHS),White House Office	80000		0	0	2022-07-12T11:45:48-04:00